PTPN11 and neoplasm: A recent finding demonstrated that SHP2 inhibition in tumor cells increases the expression of CXCR2 ligands, which suppresses M2 macrophages and promotes gMDSC infiltration, suggesting combined inhibition of SHP2 and CXCR2 in lung cancer62.